Cargando…

Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa

South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron’s attenuated clinical sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Kaiyuan, Tempia, Stefano, Kleynhans, Jackie, von Gottberg, Anne, McMorrow, Meredith L, Wolter, Nicole, Bhiman, Jinal N., Moyes, Jocelyn, Carrim, Maimuna, Martinson, Neil A, Kahn, Kathleen, Lebina, Limakatso, du Toit, Jacques D., Mkhencele, Thulisa, Viboud, Cécile, Cohen, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413704/
https://www.ncbi.nlm.nih.gov/pubmed/36032973
http://dx.doi.org/10.1101/2022.08.19.22278993
_version_ 1784775815156727808
author Sun, Kaiyuan
Tempia, Stefano
Kleynhans, Jackie
von Gottberg, Anne
McMorrow, Meredith L
Wolter, Nicole
Bhiman, Jinal N.
Moyes, Jocelyn
Carrim, Maimuna
Martinson, Neil A
Kahn, Kathleen
Lebina, Limakatso
du Toit, Jacques D.
Mkhencele, Thulisa
Viboud, Cécile
Cohen, Cheryl
author_facet Sun, Kaiyuan
Tempia, Stefano
Kleynhans, Jackie
von Gottberg, Anne
McMorrow, Meredith L
Wolter, Nicole
Bhiman, Jinal N.
Moyes, Jocelyn
Carrim, Maimuna
Martinson, Neil A
Kahn, Kathleen
Lebina, Limakatso
du Toit, Jacques D.
Mkhencele, Thulisa
Viboud, Cécile
Cohen, Cheryl
author_sort Sun, Kaiyuan
collection PubMed
description South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron’s attenuated clinical severity, and an increased risk of reinfection, the size of the Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly understood in South Africa and in many other countries. Using South African data from urban and rural cohorts closely monitored since the beginning of the pandemic, we analyzed sequential serum samples collected before, during, and after the Omicron BA.1/2 wave to infer infection rates and monitor changes in the immune histories of participants over time. Omicron BA.1/2 infection attack rates reached 65% (95% CI, 60% – 69%) in the rural cohort and 58% (95% CI, 61% – 74%) in the urban cohort, with repeat infections and vaccine breakthroughs accounting for >60% of all infections at both sites. Combined with previously collected data on pre-Omicron variant infections within the same cohorts, we identified 14 distinct categories of SARS-CoV-2 antigen exposure histories in the aftermath of the Omicron BA.1/2 wave, indicating a particularly fragmented immunologic landscape. Few individuals (<6%) remained naïve to SARS-CoV-2 and no exposure history category represented over 25% of the population at either cohort site. Further, cohort participants were more than twice as likely to get infected during the Omicron BA.1/2 wave, compared to the Delta wave. Prior infection with the ancestral strain (with D614G mutation), Beta, and Delta variants provided 13% (95% CI, −21% – 37%), 34% (95% CI, 17% – 48%), and 51% (95% CI, 39% – 60%) protection against Omicron BA.1/2 infection, respectively. Hybrid immunity (prior infection and vaccination) and repeated prior infections (without vaccination) reduced the risks of Omicron BA.1/2 infection by 60% (95% CI, 42% – 72%) and 85% (95% CI, 76% – 92%) respectively. Reinfections and vaccine breakthroughs had 41% (95% CI, 26% – 53%) lower risk of onward transmission than primary infections. Our study sheds light on a rapidly shifting landscape of population immunity, along with the changing characteristics of SARS-CoV-2, and how these factors interact to shape the success of emerging variants. Our findings are especially relevant to populations similar to South Africa with low SARS-CoV-2 vaccine coverage and a dominant contribution of immunity from prior infection. Looking forward, the study provides context for anticipating the long-term circulation of SARS-CoV-2 in populations no longer naïve to the virus.
format Online
Article
Text
id pubmed-9413704
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-94137042022-08-27 Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa Sun, Kaiyuan Tempia, Stefano Kleynhans, Jackie von Gottberg, Anne McMorrow, Meredith L Wolter, Nicole Bhiman, Jinal N. Moyes, Jocelyn Carrim, Maimuna Martinson, Neil A Kahn, Kathleen Lebina, Limakatso du Toit, Jacques D. Mkhencele, Thulisa Viboud, Cécile Cohen, Cheryl medRxiv Article South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron’s attenuated clinical severity, and an increased risk of reinfection, the size of the Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly understood in South Africa and in many other countries. Using South African data from urban and rural cohorts closely monitored since the beginning of the pandemic, we analyzed sequential serum samples collected before, during, and after the Omicron BA.1/2 wave to infer infection rates and monitor changes in the immune histories of participants over time. Omicron BA.1/2 infection attack rates reached 65% (95% CI, 60% – 69%) in the rural cohort and 58% (95% CI, 61% – 74%) in the urban cohort, with repeat infections and vaccine breakthroughs accounting for >60% of all infections at both sites. Combined with previously collected data on pre-Omicron variant infections within the same cohorts, we identified 14 distinct categories of SARS-CoV-2 antigen exposure histories in the aftermath of the Omicron BA.1/2 wave, indicating a particularly fragmented immunologic landscape. Few individuals (<6%) remained naïve to SARS-CoV-2 and no exposure history category represented over 25% of the population at either cohort site. Further, cohort participants were more than twice as likely to get infected during the Omicron BA.1/2 wave, compared to the Delta wave. Prior infection with the ancestral strain (with D614G mutation), Beta, and Delta variants provided 13% (95% CI, −21% – 37%), 34% (95% CI, 17% – 48%), and 51% (95% CI, 39% – 60%) protection against Omicron BA.1/2 infection, respectively. Hybrid immunity (prior infection and vaccination) and repeated prior infections (without vaccination) reduced the risks of Omicron BA.1/2 infection by 60% (95% CI, 42% – 72%) and 85% (95% CI, 76% – 92%) respectively. Reinfections and vaccine breakthroughs had 41% (95% CI, 26% – 53%) lower risk of onward transmission than primary infections. Our study sheds light on a rapidly shifting landscape of population immunity, along with the changing characteristics of SARS-CoV-2, and how these factors interact to shape the success of emerging variants. Our findings are especially relevant to populations similar to South Africa with low SARS-CoV-2 vaccine coverage and a dominant contribution of immunity from prior infection. Looking forward, the study provides context for anticipating the long-term circulation of SARS-CoV-2 in populations no longer naïve to the virus. Cold Spring Harbor Laboratory 2022-08-22 /pmc/articles/PMC9413704/ /pubmed/36032973 http://dx.doi.org/10.1101/2022.08.19.22278993 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Sun, Kaiyuan
Tempia, Stefano
Kleynhans, Jackie
von Gottberg, Anne
McMorrow, Meredith L
Wolter, Nicole
Bhiman, Jinal N.
Moyes, Jocelyn
Carrim, Maimuna
Martinson, Neil A
Kahn, Kathleen
Lebina, Limakatso
du Toit, Jacques D.
Mkhencele, Thulisa
Viboud, Cécile
Cohen, Cheryl
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
title Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
title_full Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
title_fullStr Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
title_full_unstemmed Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
title_short Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
title_sort rapidly shifting immunologic landscape and severity of sars-cov-2 in the omicron era in south africa
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413704/
https://www.ncbi.nlm.nih.gov/pubmed/36032973
http://dx.doi.org/10.1101/2022.08.19.22278993
work_keys_str_mv AT sunkaiyuan rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT tempiastefano rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT kleynhansjackie rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT vongottberganne rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT mcmorrowmeredithl rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT wolternicole rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT bhimanjinaln rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT moyesjocelyn rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT carrimmaimuna rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT martinsonneila rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT kahnkathleen rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT lebinalimakatso rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT dutoitjacquesd rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT mkhencelethulisa rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT viboudcecile rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT cohencheryl rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica
AT rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica